Are you looking to stay current with all of the latest Pulmonology news articles and research? Look no further! MDLinx Pulmonology medical editors extensively research respiratory medical journals to find the most beneficial Pulmonology clinical literature. Topics range from: Pediatric Pulmonology, Sleep Disorders, Asthma, COPD, Cystic Fibrosis and much more. In a matter of minutes, Pulmonologists and their staff can stay up to date with the most current published information.
On this page, you'll also find MDLinx exclusive content, including monthly highlights from our physician editor, D. Scott Cunningham, MD, PhD. We also feature clinical pearls from our Internal Medicine Physician Review. You can also get the latest updates on salary information, search available Pulmonology jobs, view upcoming Pulmonology and CME conferences and earn some extra cash by participating in Market Research opportunities.
Not yet an MDLinx.com Member??? Sign up now to gain access to MDLinx exclusive content, email alerts that keep you current on the latest medical news, research, and clinical articles on the topics of your choice, special communications and offers from MDLinx and our sponsors. Plus, you can now post your CV to the MDLinx Career Center to be viewed top medical recruiters who will help you find your next dream job.
Your Unread Messages in Pulmonology
See All >> Messages include industry-sponsored communications and special communications from MDLinx
Patients 50+ may be at increased risk for pneumococcal disease. Learn what you can do.
Smartest Doc Challenge
MDLinx
Pediatric Pulmonology Clinical Pearls
D Scott Cunningham MD, PhD
Site Editor, MDLinx
Risk factors for MRSA
Jill Baker
MDLinx Career Center
New Jobs in Your Specialty
MDLinx Top Read
MDLinx
Are your journals collecting cobwebs?
MDLinx Conference Center
MDLinx
June Conference Calendar
321 Human Lung Cancer-associated Fibroblasts Enhance Motility of Non-small Cell Lung Cancer Cells in Co-culture Anticancer Research, May 7, 2013 Clinical Article
322 Pre-emptive skin toxicity treatment for anti-EGFR drugs: evaluation of efficacy of skin moisturizers and lymecycline. A phase II study Supportive Care in Cancer, May 7, 2013 Clinical Article
323 Usefulness of Transesophageal Bronchoscopic Ultrasound-guided Fine-Needle Aspiration in the Pathologic and Molecular Diagnosis of Lung Cancer Lesions Adjacent to the Esophagus Journal of Bronchology & Interventional Pulmonology, May 7, 2013 Clinical Article
324 Randomized phase II trial of uracil/tegafur and cisplatin versus vinorelbine and cisplatin with concurrent thoracic radiotherapy for locally advanced unresectable stage III non-small-cell lung cancer: NJLCG 0601 Lung Cancer, May 6, 2013 Clinical Article
325 A pilot study for the early assessment of the effects of BMS-754807 plus gefitinib in an H292 tumor model by [18F]fluorothymidine-positron emission tomography Investigational New Drugs, May 6, 2013 Clinical Article
326 Occupational therapy needs of patients with thoracic cancer at the time of diagnosis: findings of a dedicated rehabilitation service Supportive Care in Cancer, May 6, 2013 Clinical Guideline Clinical Article
327 Lung adenocarcinoma subtypes based on expression of human airway basal cell genes European Respiratory Journal , May 6, 2013 Clinical Article
328 Combination of protein coding and non-coding gene expression as a robust prognostic classifier in stage I lung adenocarcinoma Cancer Research, May 6, 2013 Review Article
329 IGF-1R targeting increases the antitumor effects of DNA damaging agents in SCLC model: an opportunity to increase the efficacy of standard therapy Molecular Cancer Therapeutics, May 6, 2013 Clinical Article
330 Diagnosis of Lung Cancer in Small Biopsies and Cytology: Implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification Full Text Archives of Pathology & Laboratory Medicine, May 6, 2013 Review Article
331 EGFR and KRAS mutational profiling in fresh non-small cell lung cancer (NSCLC) cells Journal of Cancer Research & Clinical Oncology, May 6, 2013 Clinical Article
332 Illness-Related Emotional Experiences of Patients Living With Incurable Lung Cancer: A Qualitative Metasynthesis Cancer Nursing, May 6, 2013 Clinical Article
333 Evidence for tankyrases as antineoplastic targets in lung cancer Full Text BMC Cancer, May 3, 2013 Clinical Article
334 Real-World Effectiveness of Systemic Agents Approved for Advanced Non-Small Cell Lung Cancer: A SEER-Medicare Analysis Full Text The Oncologist, May 3, 2013 Clinical Article
335 Intratumour variation of biomarker expression by immunohistochemistry in resectable non-small cell lung cancer European Journal of Cancer, May 3, 2013 Clinical Article
336 Role of ultrasound-guided transbronchial biopsy in the diagnosis of peripheral pulmonary lesions Lung Cancer, May 3, 2013 Clinical Article
337 Role of p38 and JNK MAPK signaling pathways and tumor suppressor p53 on induction of apoptosis in response to Ad-eIF5A1 in A549 lung cancer cells Full Text Molecular Cancer, May 3, 2013 Clinical Article
338 A Novel Sulindac Derivative Inhibits Lung Adenocarcinoma Cell Growth through Suppression of Akt/mTOR Signaling and Induction of Autophagy Molecular Cancer Therapeutics, May 3, 2013 Clinical Article
339 Pulmonary pleomorphic carcinoma with rapid progression Asian Cardiovascular and Thoracic Annals, May 3, 2013
340 Survival After Extended Resection for Mediastinal Advanced Lung Cancer: Lessons Learned on 167 Consecutive Cases Annals of Thoracic Surgery, May 2, 2013 Review Article
Using a murine mouse model of pneumonia, prolonged simvastatin therapy has a measureable effect on Streptococcus pneumoniae infection, but no effect on mortality. Mice were treated with simvastatin (1 mg/kg/d [low dose] or 10 mg/kg/d [high dose]) for 4 weeks, then infected with S. pneumoniae intrathecally. Mice treated with the high-dose regimen had less lung consolidation, decreased macrophage and neutrophil infiltration, decreased MCP-1, KC, and ICAM-1 production, and decreased bacterial titers in the blood 36 and 42 h post-infection. Despite these favorable physiologic effects, there was no effect on mortality compared to control mice treated with ampicillin 48 h post-infection.
Read the article summaryAs published in the European Journal of Internal Medicine, there were no mortalities in patients with community-acquired pneumonia (CAP) and low levels of D-dimer (< 500 ug/l). Of 147 patients in the study, D-dimer levels were elevated in those with severe CAP (2166 vs. 1630 ug/l), day 30-clinical failure (2228 vs. 1594 ug/l), early failure (2499 vs. 1669 ug/l), and non-survivors (3025 vs. 1680 ug/l). Importantly, D-dimer levels were not shown to be associated with clinical outcome based on multivariate analysis.
Read the article summaryAs published in the Journal of Infection, 114 of 981 (11.6%) of patients with pneumococcal pneumonia were bacteremic. Risk factors for bacteremia included immunosuppressants, age < 65 years, and diabetes mellitus. Patients with pneumococcal pneumonia and bacteria were at increased risk for mortality (28.6% vs. 8.5%). The combination of bacteremia, cerebrovascular disease, and septic shock had a strong association with mortality in patients with pneumococcal pneumonia.
Read the article summary1 Indirectly estimated absolute lung cancer mortality rates by smoking status and histological type based on a systematic review BMC Cancer, April 15, 2013 Free full text Evidence Based Medicine Review Article
2 Relevance of an extensive follow-up after surgery for non-small cell lung cancer European Respiratory Journal , March 25, 2013 Clinical Guideline
3 New dilemmas in small-cell lung cancer TNM clinical staging OncoTargets and Therapy, May 17, 2013 Free full text
4 Deubiquitinase inhibition of 19s regulatory particles by 4-arylidene curcumin analogue ac17 causes nf-{kappa}b inhibition and p53 reactivation in human lung cancer cells Molecular Cancer Therapeutics, May 23, 2013
5 Results of initial low-dose computed tomographic screening for lung cancer New England Journal of Medicine, May 24, 2013 Evidence Based Medicine
6 Risk factors for predicting the occult nodal metastasis in T1-2N0M0 NSCLC patients staged by PET/CT: Potential value in the clinic Lung Cancer, May 14, 2013
7 The ground glass opacity component can be eliminated from the T-factor assessment of lung adenocarcinoma European Journal of Cardio-Thoracic Surgery, April 11, 2013
8 Factors affecting local progression after percutaneous cryoablation of lung tumors Journal of Vascular and Interventional Radiology, May 23, 2013
9 Long-Term Results of a Randomized, Double-Blind, and Placebo-Controlled Phase III Trial: Endostar (rh-Endostatin) Versus Placebo in Combination with Vinorelbine and Cisplatin in Advanced Non-Small Cell Lung Cancer Thoracic Cancer, May 8, 2013
10 What predicts the risk of recurrent lung metastases? Journal of Pediatric Surgery, May 23, 2013
11 Impact of Smoking on Mortality of Patients with Non-Small Cell Lung Cancer Thoracic Cancer, May 10, 2013 Review Article
12 Erlotinib in the first-line treatment of non-small-cell lung cancer Expert Review of Anticancer Therapy, May 9, 2013
13 Stage IIIA Non-Small Cell Lung Cancer: Morbidity and Mortality of Three Distinct Multimodality Regimens Annals of Thoracic Surgery, May 2, 2013 Review Article
14 Magnetic Resonance Imaging for Lung Cancer Journal of Thoracic Imaging, April 29, 2013 Review Article
15 Is lobectomy really more effective than sublobar resection in the surgical treatment of second primary lung cancer? European Journal of Cardio-Thoracic Surgery, May 14, 2013
16 Recurrent response to advanced lung adenocarcinoma with erlotinib developing leptomeningeal metastases during gefitinib therapy and 2 case report Thoracic Cancer, May 1, 2013
17 Independent of ErbB1 gene copy number, EGF stimulates migration but is not associated with cell proliferation in non-small cell lung cancer Cancer Cell International, May 1, 2013
18 Advantages of Diffusion-Weighted Imaging Over Positron Emission Tomography-Computed Tomography in Assessment of Hilar and Mediastinal Lymph Node in Lung Cancer Annals of Surgical Oncology, April 29, 2013
19 Crizotinib for the treatment of non-small-cell lung cancer American Journal of Health-System Pharmacy, May 23, 2013
20 Pleural Plaques and the Risk of Pleural Mesothelioma Journal of the National Cancer Institute, January 28, 2013
Indexed Journals in Pulmonology: Chest, Thorax, American Journal of Respiratory and Critical Care Medicine more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close